- Report
- March 2025
- 186 Pages
Global
From €3943EUR$4,500USD£3,402GBP
- Report
- February 2025
- 182 Pages
Global
From €3943EUR$4,500USD£3,402GBP
- Report
- November 2025
- 250 Pages
Global
From €3934EUR$4,490USD£3,395GBP
- Report
- January 2026
- 181 Pages
Global
From €3943EUR$4,500USD£3,402GBP
- Report
- February 2026
- 471 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- February 2026
- 384 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- February 2026
- 285 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- February 2026
- 193 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- September 2025
- 150 Pages
Global
From €3417EUR$3,900USD£2,949GBP
- Report
- May 2025
- 120 Pages
Global
From €4162EUR$4,750USD£3,591GBP
- Report
- May 2025
- 138 Pages
Global
From €4162EUR$4,750USD£3,591GBP
- Report
- May 2025
- 118 Pages
Global
From €4162EUR$4,750USD£3,591GBP
- Report
- August 2025
- 138 Pages
Global
From €3504EUR$3,999USD£3,023GBP
- Report
- August 2025
- 148 Pages
Global
From €3504EUR$3,999USD£3,023GBP
- Report
- August 2025
- 145 Pages
Global
From €3504EUR$3,999USD£3,023GBP
- Report
- June 2025
- 150 Pages
Global
From €3504EUR$3,999USD£3,023GBP
- Report
- June 2025
- 145 Pages
Global
From €3504EUR$3,999USD£3,023GBP
- Report
- June 2025
- 150 Pages
Global
From €3504EUR$3,999USD£3,023GBP
- Report
- May 2025
- 140 Pages
Global
From €3504EUR$3,999USD£3,023GBP
- Report
- April 2025
- 142 Pages
Global
From €3504EUR$3,999USD£3,023GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more